INFLAMMATORY BOWEL DISEASES

Scope & Guideline

Connecting science and clinical practice for better outcomes.

Introduction

Delve into the academic richness of INFLAMMATORY BOWEL DISEASES with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1078-0998
PublisherOXFORD UNIV PRESS INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1995 to 2024
AbbreviationINFLAMM BOWEL DIS / Inflamm. Bowel Dis.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressJOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513

Aims and Scopes

The journal 'Inflammatory Bowel Diseases' is dedicated to the comprehensive exploration and dissemination of research related to inflammatory bowel diseases (IBD), particularly Crohn's disease and ulcerative colitis. Its aims encompass a broad spectrum of topics that include clinical management, epidemiology, pathophysiology, and advancements in therapeutic approaches.
  1. Clinical Management and Therapeutics:
    The journal focuses on clinical strategies for managing IBD, including the evaluation and effectiveness of various treatment modalities such as biologics, immunomodulators, and surgical interventions.
  2. Epidemiology and Public Health:
    Research articles often address the epidemiological trends, risk factors, and healthcare utilization patterns associated with IBD, contributing to a better understanding of the disease burden across different populations.
  3. Pathogenesis and Molecular Mechanisms:
    The journal emphasizes studies exploring the underlying biological mechanisms of IBD, including genetic, immunological, and microbiome-related factors that contribute to disease development and progression.
  4. Patient-Centered Outcomes and Quality of Life:
    There is a strong focus on understanding the impact of IBD on patients' quality of life, including studies on psychological aspects, social determinants of health, and patient-reported outcomes.
  5. Innovative Research Techniques:
    The journal encourages the use of advanced research methodologies, including machine learning, biomarker discovery, and novel therapeutic approaches, to enhance the understanding and treatment of IBD.
Recent publications in 'Inflammatory Bowel Diseases' have highlighted several emerging themes that reflect the evolving landscape of research in this field. These trends indicate a shift towards more innovative, personalized, and integrative approaches to IBD management.
  1. Microbiome Research:
    There is a growing emphasis on the role of the gut microbiome in IBD, with studies exploring microbial signatures, their impact on disease activity, and potential therapeutic applications of microbiome modulation.
  2. Telemedicine and Digital Health:
    The integration of telemedicine into IBD management has emerged as a significant theme, particularly in response to the COVID-19 pandemic, highlighting the need for accessible care and patient engagement.
  3. Psychosocial Factors and Mental Health:
    Research focusing on the psychological impact of IBD, including anxiety, depression, and patient coping strategies, has gained traction, recognizing the importance of mental health in disease management.
  4. Precision Medicine and Biomarkers:
    The journal is increasingly publishing studies on precision medicine approaches, including the identification of biomarkers for treatment response, which aim to tailor therapies to individual patient profiles.
  5. Innovative Therapeutic Strategies:
    There is a surge in research related to novel therapeutics, including the use of biologics, small molecules, and combination therapies, indicating a shift towards more effective and targeted treatment options.

Declining or Waning

While the journal continues to cover a wide range of topics related to inflammatory bowel diseases, certain themes have shown a decline in focus over recent years. This may reflect shifts in research priorities or changes in the clinical landscape.
  1. Traditional Dietary Interventions:
    Research on conventional dietary interventions in IBD, such as low-residue diets, has decreased, possibly due to a growing emphasis on personalized nutrition and the microbiome's role in disease management.
  2. Opioid Use Management:
    The frequency of studies specifically addressing opioid use management in IBD patients has waned, perhaps as alternative pain management strategies and the opioid crisis have shifted research focus.
  3. Classic Surgical Techniques:
    There seems to be a diminishing emphasis on traditional surgical approaches for IBD, as newer minimally invasive techniques and biologic therapies gain prominence in clinical practice.
  4. Epidemiological Studies in Specific Regions:
    Research focusing on localized epidemiological studies has decreased, indicating a potential shift towards more global or multi-center studies that consider diverse populations.
  5. Historical Perspectives on IBD Treatment:
    The journal has seen a reduction in articles discussing historical treatment methodologies, as the focus shifts toward current and future therapeutic innovations.

Similar Journals

Canadian Journal of Gastroenterology and Hepatology

Your Gateway to Cutting-edge Gastroenterology Insights
Publisher: HINDAWI LTDISSN: 2291-2789Frequency: 1 issue/year

Canadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.

WORLD JOURNAL OF GASTROENTEROLOGY

Leading the way in gastrointestinal research excellence.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1007-9327Frequency: 48 issues/year

WORLD JOURNAL OF GASTROENTEROLOGY, published by BAISHIDENG PUBLISHING GROUP INC, stands at the forefront of gastrointestinal research, providing a critical platform for the dissemination of high-quality studies in the field. With an impressive impact factor reflected in its Q1 rankings in both Gastroenterology and Miscellaneous Medicine, this journal is recognized for its rigorous peer-review process and commitment to advancing knowledge and practices related to digestive health. Covering comprehensive scopes from clinical advancements to innovative therapies, the journal serves an essential role for researchers, clinicians, and students, enabling them to stay updated on the latest developments and findings from 1998 through 2024. The open access model facilitates broader accessibility, ensuring that groundbreaking research reaches a global audience. The journal's ranking within the top 15% of Scopus demonstrates its significant contribution to the academic community, making it a valuable resource for advancing the science of gastroenterology.

CURRENT OPINION IN GASTROENTEROLOGY

Empowering Professionals with Cutting-Edge Insights
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0267-1379Frequency: 6 issues/year

CURRENT OPINION IN GASTROENTEROLOGY is a prestigious peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the latest advancements and emerging trends within the field of gastroenterology. Established in 1990, the journal has consistently provided a platform for researchers and practitioners to share insights and foster discussions on critical and evolving topics, making it a valuable resource for healthcare professionals and students alike. With its current ranking in the Q2 category of gastroenterology journals and a respectable 67th percentile in Scopus rankings, CURRENT OPINION IN GASTROENTEROLOGY strives to contribute significantly to clinical practices and research methodologies. Although it does not offer open access options, the journal is known for its rigorously curated articles that shape the future of gastroenterology, providing readers with comprehensive reviews and expert opinions. By covering a diverse range of topics, this journal aims to bridge the gap between research and practical application, reinforcing its role as a leader in advancing knowledge within the gastrointestinal field.

GUT

Transforming Knowledge into Digestive Health Solutions
Publisher: BMJ PUBLISHING GROUPISSN: 0017-5749Frequency: 12 issues/year

GUT is a premier journal in the field of gastroenterology, published by the esteemed BMJ Publishing Group. With a rich history dating back to 1960 and an impressive convergence of research expected to continue through 2024, GUT has established itself as a cornerstone of academic discourse in the gastrointestinal sciences. The journal boasts a remarkable impact factor, positioning it in the Q1 category for gastroenterology with an outstanding rank of #3 out of 167 in its Scopus ranking, reflecting its 98th percentile status among peers. Although it does not currently offer open access options, GUT remains dedicated to disseminating high-quality research, reviews, and clinical studies that advance the understanding of digestive health. Published in the United Kingdom, GUT serves as an essential resource for researchers, clinicians, and students aiming to stay at the forefront of innovations and developments in the field.

BMJ Open Gastroenterology

Empowering Global Insights in Gastrointestinal Medicine
Publisher: BMJ PUBLISHING GROUPISSN: 2054-4774Frequency: 1 issue/year

BMJ Open Gastroenterology is a premier open access journal published by the esteemed BMJ Publishing Group, focusing on the dynamic and evolving field of gastroenterology. Established in 2014, the journal has rapidly ascended in stature, reflected in its impressive 2023 Q1 ranking in gastroenterology and its position within the top 25% of journals in the category according to Scopus. With a mission to disseminate high-quality, peer-reviewed research with global significance, the journal provides a vital platform for researchers, professionals, and students alike to share their findings and advancements in gastrointestinal medicine. Operating from its headquarters in London, England, the journal's open access format ensures wide visibility and accessibility of cutting-edge research, making it an invaluable resource for those dedicated to improving patient care and driving innovation in gastroenterological sciences. By engaging with this journal, contributors and readers can stay at the forefront of critical developments in the field, fostering a collaborative environment for knowledge exchange.

PRACTICAL GASTROENTEROLOGY

Navigating the Frontiers of Gastroenterology Research
Publisher: SHUGAR PUBLISHING INCISSN: 0277-4208Frequency: 12 issues/year

PRACTICAL GASTROENTEROLOGY is a distinguished journal dedicated to the field of gastroenterology, published by Shugar Publishing Inc in the United States. With an ISSN of 0277-4208, the journal serves as a pivotal resource for medical professionals, researchers, and students keen on staying abreast of the latest advancements and practical applications in gastrointestinal health. Although it does not currently operate under an Open Access model, it has been a respected publication since its inception, spanning significant years of research from 1989 to 2013 and resuming again from 2016 to 2023. Despite holding a current Q4 ranking in Gastroenterology with Scopus, its commitment to quality insights provides a platform for critical information dissemination, making it an essential read for those engaged in clinical practice and academic research. The journal’s objectives include addressing practical challenges in gastroenterology, bridging the gap between research and clinical implementation, and fostering ongoing education among practitioners in this dynamic field.

HPB

Connecting researchers for a healthier future in Hepatology.
Publisher: ELSEVIER SCI LTDISSN: 1365-182XFrequency: 12 issues/year

HPB is a premier journal dedicated to advancing the fields of Gastroenterology and Hepatology, published by Elsevier Science Ltd. With an impressive impact factor reflective of its high-quality research output, HPB has earned its place as a Q1 journal in Gastroenterology and Q2 in Hepatology as of 2023. The journal, available in both print and electronic formats (ISSN: 1365-182X; E-ISSN: 1477-2574), serves as a vital platform for multidisciplinary research, encompassing clinical and experimental studies, aimed at improving patient care and outcomes related to liver and biliary diseases. Since its inception in 2000, HPB has published influential articles that have shaped practice and policy in the field. Located in the United Kingdom, at 125 London Wall, London EC2Y 5AS, the journal is poised to continue its mission of fostering innovation and collaboration among researchers, healthcare professionals, and academicians worldwide.

DIGESTION

Delivering high-quality research to transform digestive health.
Publisher: KARGERISSN: 0012-2823Frequency: 6 issues/year

DIGESTION is a prestigious journal dedicated to advancing the field of gastroenterology, published by KARGER, a renowned publisher based in Switzerland. With a rich history dating back to 1896, this journal has continuously evolved and serves as a vital platform for researchers, professionals, and students alike. DIGESTION is recognized for its scholarly contributions, holding an impressive rank of 23 out of 167 in the Scopus database, placing it within the top 14% of gastroenterology journals, as evidenced by its Q2 classification. The journal's commitment to high-quality research is reflected in its wide-ranging scope, addressing various aspects of digestive health, clinical practices, and innovative therapies. Though not an open-access journal, it provides comprehensive access options that ensure the dissemination of crucial research findings to the global community. As we move towards 2024, DIGESTION continues to facilitate dialogue and insights in gastroenterological research, making it an indispensable resource for those in the field.

OCULAR IMMUNOLOGY AND INFLAMMATION

Exploring the complexities of immune responses in the eye.
Publisher: TAYLOR & FRANCIS INCISSN: 0927-3948Frequency: 6 issues/year

Ocular Immunology and Inflammation is a distinguished academic journal dedicated to advancing the field of ocular immunology and ophthalmic inflammation. Published by Taylor & Francis Inc, this journal plays a crucial role in disseminating high-quality research findings, reviews, and clinical studies that address the complexities of immune responses in the eye and their implications in various ocular diseases. With an impressive impact factor and consistently ranking in the Q2 category in both Immunology and Allergy and Ophthalmology, it stands out as a vital resource for researchers, clinicians, and students alike. The journal's broad scope encompasses both experimental and clinical studies, ensuring a comprehensive exploration of the mechanisms and treatments of ocular inflammatory conditions. With its publication history dating from 1993 to 2024, this journal continues to be an essential reference for those seeking cutting-edge research and insights into ocular health. Researchers and professionals are encouraged to engage with the latest articles to inform their practice and advance their knowledge in this critical area of medicine.

Crohns & Colitis 360

Championing collaboration in Crohn's and colitis research.
Publisher: OXFORD UNIV PRESSISSN: Frequency: 4 issues/year

Crohns & Colitis 360, published by Oxford University Press, is a leading open access journal that has been at the forefront of gastrointestinal research since its launch in 2019. With an E-ISSN of 2631-827X, this journal aims to foster innovation and collaboration within the field of gastroenterology, focusing on diseases such as Crohn's disease and ulcerative colitis. As of 2023, it has earned a commendable Q2 ranking in the gastroenterology category, positioning it among the top 50% of journals in its field, with a Scopus rank of 99 out of 167. Crohns & Colitis 360 not only provides a platform for peer-reviewed research but also seeks to disseminate clinical guidelines, reviews, and groundbreaking studies, making it an essential resource for researchers, healthcare professionals, and students dedicated to advancing the understanding and treatment of inflammatory bowel diseases. Emphasizing accessibility, the journal has been open access since its inception, ensuring that cutting-edge research is readily available to a global audience. This commitment to knowledge sharing significantly enhances its impact and relevance in the ever-evolving landscape of gastroenterology.